- 10-07-25 – ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
- 11-04-25 – ImmuCell Announces Onboarding of New CEO and Related Management Changes
- 11-06-25 – ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
- 11-13-25 – ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
- 12-24-25 ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
- 01-07-26 ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
- 01-08-26 ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
Upcoming Conference Calls
- Fourth Quarter and Fiscal Year 2025 Conference Call
Thursday, February 26, 2026 at 9:00 AM ET
Most Recent Conference Call
01-09-2026 – ImmuCell Management Reviews Strategic Focus on First Defense
Audio Replay